Moreover, previous studies have reported that IL15 superagonist-stimulated NK cells enhance in vivo antitumor efficacy by promoting tumor infiltration [30], and IL15-expanded KLRG1+ NK cells protect mice from pulmonary metastatic colorectal carcinoma [10]. This evidence concerns the gene KLRG1 and neoplasm.